Should You Buy SpaceX Stock 11% Below Its IPO Price?

The real issue is not the test-failure noise; it is whether the company can keep funding a very capital-intensive roadmap without the market forcing a lower terminal multiple. When an asset trades on narrative rather than current profitability, any delay in proving unit economics usually shows up first as multiple compression, not operating-loss disappointment.

If the AI spend figures are directionally right, that creates a second-order crowding-out problem: every incremental dollar allocated to long-dated optionality raises the hurdle for near-term execution in the core connectivity/space franchises. That is structurally negative for SPCX because investors typically tolerate capex only when it shortens time-to-monetization; here, it appears to extend it. By contrast, suppliers with real cash conversion and lower funding needs—especially NVDA if the spend is genuine—look comparatively cleaner, while smaller adjacent space names such as TSTS could benefit if capital rotates away from the most expensive story stock.

Near term, this is an event-risk trade, not a secular collapse call. A successful retry next week could trigger a relief bounce, but the intermediate path is still defined by disclosure around capex discipline, loss trajectory, and whether management can show any payback from the AI bucket within 1-3 quarters. The thesis is falsified if the next launch succeeds cleanly and the company follows with evidence that spending growth is moderating faster than revenue growth stalls.